Longitudinal Study for Relapsing Polychondritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Pennsylvania
About this trial
Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
1. Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.
Disqualifiers
1. Inability to provide consent, or in the case of minors, assent.
Trial population
Individuals with relapsing polychondritis (RP). Enrollment will be sequential and participants will have disease in various stages and of different duration.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: Relapsing Polychondritis Cohort
Trial outcomes
Primary outcomes
1
Evaluate the pathogenesis of relapsing polychondritis using disease history.
To study the manner of development of disease in patients affected with relapsing polychondritis.
Time frame
Study completion; from baseline through month 36.Secondary outcomes
1
PROMIS Questionnaires
Questions will ask about fatigue on the PROMIS short form.
Time frame
Baseline, month 6, month 12, month 18, month 24, month 30, month 362
PROMIS Questionnaires
Questions will ask about pain interference on the PROMIS short form.
Time frame
Baseline, month 6, month 12, month 18, month 24, month 30, month 363
PROMIS Questionnaires
Questions will ask about physical function on the PROMIS short form.
Time frame
Baseline, month 6, month 12, month 18, month 24, month 30, month 364
PROMIS Questionnaires
Questions will ask about global health on the PROMIS short form.
Time frame
Baseline, month 6, month 12, month 18, month 24, month 30, month 36Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov